GlassScriptPhysician profile
Ryan Elizabeth Benner
NPI 1578172151
$11,941.60
in general payments reported to CMS, 2019-2025
54 companies · $2,822 in 2025
The $2,822 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2021: $2,131 · 2022: $1,863 · 2023: $2,424 · 2024: $2,701 · 2025: $2,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,831 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,830.51 |
| Education | $116.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,168.69 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,142.34 | 2021-2025 | Tepezza, Evenity, Prolia |
| Lilly USA, LLC | $1,043.90 | 2022-2025 | Mounjaro, Zepbound, Lyumjev |
| Sanofi-Aventis U.S. LLC | $755.45 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $632.54 | 2021-2023 | Farxiga |
| Dexcom, INC. | $599.70 | 2021-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $548.48 | 2021-2025 | Jardiance |
| Beta Bionics, INC. | $422.27 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Abbvie INC. | $411.07 | 2021-2025 | |
| Cequr Corporation | $404.94 | 2022-2025 | Cequr Simplicity |
| Alexion Pharmaceuticals, INC. | $317.36 | 2021-2023 | Strensiq |
| Nevro Corp. | $304.04 | 2023-2024 | Senza |
| Corcept Therapeutics | $289.35 | 2021-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $271.85 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Tandem Diabetes Care, INC. | $267.93 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $263.36 | 2021-2025 | Omnipod, Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $250.27 | 2021-2025 | |
| Radius Health, INC. | $242.82 | 2022-2025 | Tymlos |
| Amarin Pharma, INC. | $236.02 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $213.18 | 2024-2025 | |
| Alvogen INC | $163.40 | 2024-2025 | Teriparatide |
| Amneal Pharmaceuticals LLC | $161.41 | 2023-2025 | Unithroid |
| Horizon Therapeutics Plc | $161.29 | 2023 | Tepezza |
| Ascendis Pharma Endocrinology INC | $136.68 | 2023-2025 | Yorvipath |
| Antares Pharma, INC. | $121.17 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Pfizer INC. | $97.23 | 2022-2025 | |
| Medtronic, INC. | $92.84 | 2021-2024 | Minimed 780g |
| Ultragenyx Pharmaceutical INC. | $92.38 | 2021-2023 | |
| Eisai INC. | $87.25 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $78.97 | 2024 | |
| Abbott Laboratories | $76.27 | 2023-2025 | Freestyle Libre 3, Proclaim |
| Tolmar, INC. | $74.52 | 2025 | Jatenzo |
| Merck Sharp & Dohme LLC | $70.64 | 2021-2022 | |
| Ibsa Pharma INC. | $67.99 | 2021-2023 | Tirosint, Licart |
| Madrigal Pharmaceuticals | $67.98 | 2025 | Rezdiffra |
| Mannkind Corporation | $61.18 | 2025 | |
| Kyowa Kirin, INC. | $57.54 | 2023-2025 | Crysvita |
| Chiesi USA, INC. | $50.65 | 2025 | Mycapssa |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Endo USA, INC. | $47.69 | 2025 | Aveed |
| Halozyme INC | $38.42 | 2023 | |
| Blueprint Medicines Corporation | $35.66 | 2021-2022 | |
| Soleno Therapeutics, INC. | $34.88 | 2025 | Vykat Xr |
| Astellas Pharma US INC | $34.48 | 2025 | Veozah |
| Regeneron Healthcare Solutions, INC. | $33.34 | 2024 | Evkeeza |
| Intuity Medical INC | $32.08 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Grt US Holding, INC. | $23.30 | 2021 | |
| Globus Medical, INC. | $22.71 | 2025 | Senza |
| Zealand Pharma US, INC. | $17.00 | 2021 | |
| Avvisto Therapeutics, LLC | $16.37 | 2025 | Cycloset |
| Recordati_rare_diseases_inc. | $15.69 | 2024 | Signifor Lar, Isturisa |
| Acella Pharmaceuticals, LLC | $13.65 | 2023 | NP Thyroid 60 |
| Ascensia Diabetes Care US INC. | $11.09 | 2021 | |
| Clarus Therapeutics INC. | $10.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$126.02 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Benner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.